The Scientist

» drug discovery and developmental biology

Most Recent

image: Fellow Travelers

Fellow Travelers

By | February 1, 2013

Collective cell migration relies on a directional signal that comes from the moving cluster, rather than from external cues.

1 Comment

image: Go Forth, Cells

Go Forth, Cells

By | February 1, 2013

Watch the cell transplant experiments in zebrafish that suggest certain embryonic cells rely on intrinsic directional cues for collective migration.

0 Comments

image: Is Frog Skin a Red Herring?

Is Frog Skin a Red Herring?

By | January 2, 2013

Despite decades of work, compounds in frog skins have failed to yield new antibiotics. Why?

2 Comments

image: 2012 Multimedia Roundup

2012 Multimedia Roundup

By | December 14, 2012

The science images and videos that captured our attention in 2012

1 Comment

image: Opinion: Parachuting off the Patent Cliff

Opinion: Parachuting off the Patent Cliff

By | December 6, 2012

As the United States edges ever closer to the dreaded fiscal cliff, the pharmaceutical industry approaches a precipice of its own.

4 Comments

image: Neil Bence: Manipulating Degradation

Neil Bence: Manipulating Degradation

By | December 1, 2012

Senior Scientist, Millennium Pharmaceuticals: The Takeda Oncology Company Age: 39

0 Comments

image: Coming to Terms

Coming to Terms

By | November 1, 2012

New noninvasive methods of selecting the most viable embryo could revolutionize in vitro fertilization.

11 Comments

image: Contributors

Contributors

By | November 1, 2012

Meet some of the people featured in the November 2012 issue of The Scientist.

0 Comments

image: Tumor Snipers

Tumor Snipers

By | November 1, 2012

After two headline successes, companies rush to develop “smart bomb” cancer drugs.

0 Comments

image: Exit Strategy

Exit Strategy

By | November 1, 2012

Large RNA-protein packets use a novel mechanism to escape the cell nucleus.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech